Sensei Biotherapeutics Acquisition | Healthcare Deal in MD

Sapphire First Merger Sub, Inc. has acquired Sensei Biotherapeutics, a healthcare services other business in Maryland, for $undisclosed. Sensei Biotherapeutics operates in the healthcare services other sector, supporting life sciences and therapeutic development activities that align with healthcare M&A priorities in MD acquisitions. The merger acquisition structure brings Sensei’s corporate and operational capabilities into a Delaware merger framework, supporting merger acquisition planning for healthcare deals MD. The announced healthcare M&A transaction is structured as a merger acquisition involving multiple merger entities, with merger consideration and closing mechanics governed by an agreement and plan of merger dated February 17, 2026.